Lightning Round: BP, Merck, Starbucks and More

IDEXX Laboratories : This stock doesn’t fulfill any of Cramer’s requirements for ownership during this downturn – a company near liquidation value, completely immune to the economy or a sizable dividend – so stay away from IDXX.

Starbucks : Cramer said to wait on Starbucks for now. Howard Schultz hasn’t been back in the CEO chair long enough to turn this company around. Don’t buy.

Lightning Round
Lightning Round   

Barclays : Sell BCS, Cramer said.

VNUS Medical : Cramer thinks VNUS would make a great speculation play.

PACCAR : This market is too tough for the industrials, so be careful with PCAR, Cramer said.

Xerox : “I think it’s dead,” Cramer said. The company has too much debt, so don’t buy XRX.

Dominion Resources : Dominion is “too cheap,” Cramer said. “I think that’s a good thing to buy.”

GMX Resources : Cramer likes GMXR, and BP for its dividend yield.

Merck : Merck isn’t Cramer’s pharma play, but he likes health care so much he’ll endorse any buying of MRK. He likes Bristol-Myers Squibb and Abbott Labs better.

Deere : Management’s business execution has been so poor, Cramer can’t recommend this stock. He thinks DE drops to $20 from its present trading price of $28.89.








Cramer's charitable trust owns Abbott Labs, BP and Bristol-Myers Squibb.

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Cramer's New Book